Skip to content
Johnson & Johnson Vaccine on Hold
Go to my account

Johnson & Johnson Vaccine on Hold

This week, the FDA decided to pause the Johnson & Johnson vaccine following reports that  ...

This week, the FDA decided to pause the Johnson & Johnson vaccine following reports that  six women—of the nearly 7 million Americans who have received the J&J vaccine—developed serious blood clots after getting the jab. Is pausing the vaccine worth the tradeoffs? Will the FDA’s move fuel vaccine hesitancy? Sarah, David, Chris and Jonah give us the scoop. Today, our hosts also chat about New York Times columnist Ross Douthat’s latest piece on what Bidenism owes to Trumpism, the GOP’s First Amendment retribution against woke corporations, and what Democratic pollsters have learned from their poor electoral forecasting leading up to the 2020 election.

Show Notes:

-“What Bidenism Owes to Trumpism,” by Ross Douthat in the New York Times.

-“Confronting 2016 and 2020 Polling Limitations” by Pew Research Center.

-“How Trump Steered Supporters Into Unwitting Donations” by Shane Goldmacher in the New York Times.

Listen on your player of choice

Sarah Isgur is a senior editor at The Dispatch and is based in northern Virginia. Prior to joining the company in 2019, she had worked in every branch of the federal government and on three presidential campaigns. When Sarah is not hosting podcasts or writing newsletters, she’s probably sending uplifting stories about spiders to Jonah, who only pretends to love all animals.

Share with a friend

Your membership includes the ability to share articles with friends. Share this article with a friend by clicking the button below.

Please note that we at The Dispatch hold ourselves, our work, and our commenters to a higher standard than other places on the internet. We welcome comments that foster genuine debate or discussion—including comments critical of us or our work—but responses that include ad hominem attacks on fellow Dispatch members or are intended to stoke fear and anger may be moderated.

You are currently using a limited time guest pass and do not have access to commenting. Consider subscribing to join the conversation.

With your membership, you only have the ability to comment on The Morning Dispatch articles. Consider upgrading to join the conversation everywhere.